Procurement Support Services to the Ministry of Health of Ukraine

Project Summary


The challenges and failures of the Ministry of Health’s public procurement and supply programme resulted in a two-year gap of available medicine in the country from 2013-2015. At the request of the Ministry of Health, this project will procure a range of medicines and related medical products as an emergency measure in 2015 and ongoing years as needed. The programme will also build the capacity needed to support a transparent and cost-effective procurement system for the Ministry.

Project Goals

1.       Assist MOH in the cost-efficient, transparent and timely procurement of medicines and other medical products of selected State Health Programmes as an emergency matter. The drugs to be procured are for the diagnosis and treatment of tuberculosis, hepatitis, hemophilia and orphan diseases in children, and the diagnosis of HIV/AIDS.

2.       Build the structural and human resource capacity for supply, planning, forecasting, and monitoring and evaluation for transparent and cost-effective procurement at MOH.

3.       Progressively hand over procurement activities while supporting the procurement processes and procurement unit of MOH.

4.       Support MOH further reform of the national procurement and quality assurance system and capacity development processes.

5.       With the technical expertise of WHO, support the capacity building of the procurement and supply chain management in the context of the wider initiative aimed at strengthening the Ukrainian healthcare system and creating a coherent pharmaceutical society.



Improving public procurement in healthcare

Procurements of vital medicines through UNDP and other international organizations is a temporary measure for Ukraine for the period of up to 2019. The support provided by UNDP to the Ministry of Health is also aimed to help reform healthcare sector procurement for the period beyond 2019, in particular with the creation of a Health Products Procurement Agency (HPPA). The agency is an independent organization and will be responsible to procure medicines for the Ukrainian people using modern IT tools and transparent procedures. To support its capacity, the UNDP Healthcare Program is helping with different activities, such as:

  • Introduction of sustainable procurement practices;
  • Support to policy and legal developments, 
  • Support to capacity building events and advocacy, 
  • Provision of anti-corruption analysis/evidence and action plan,
  • Support to the advisory unit under the Ministry of Health, 
  • Support to revision of the nomenclature of medicines used by the Ministry of Health.

Among the achievements of 2016, two digital monitoring and stock management systems were launched: “E-Liky” jointly developed with the patient community in two oblasts, and digital stock management system developed with state enterprise Ukrvakcina, already piloted in 13 hospitals and soon to be rolled out. Seminars and workshops on anti-corruption, sustainable procurement and human rights took place at the ministerial and regional level. Joint activities with patient groups and civil society helped building a system of checks and balances which will ensure public oversight on the future activities of the agency.

sds

On the long term, this project focuses on strengthening public procurement in Ukraine's healthcare system, in order to ensure all citizen's access to essential medicines and other medical products in Ukraine.

On one hand, UNDP will provide support to the Ministry of Health of Ukraine in developing and implementing a strategy for reforming procurement in. This strategy will be based on the principles of transparency, accountability and effectiveness and apply integrated, issue-based and innovative approach.

On the other hand, UNDP will help develop an online medical stock system to allow real-time monitoring of and access to medical stocks, as a key element of reform. This system will help scale up the public procurement process, make medicines and other medicinal products timely available for patients, and allow appropriate forecasting and planning for medicines procurement both nationally and locally.